摘要
胰岛素瘤(insulinoma)是一种以低血糖为临床表现的肿瘤。随着近年影像学、核医学等学科发展,胰岛素瘤检出率、确诊率逐渐升高。目前细胞毒性化疗、靶向治疗、肽受体放射性核素治疗(PRRT)等最新治疗手段提高了胰岛素瘤临床治愈率。本文就胰岛素瘤发病机制、诊疗方法等方面最新进展进行综述。
Insulinoma is a type of tumor in which hypoglycemia is the clinical manifestation. With the devel-opment of imaging, nuclear medicine and other disciplines, the detection rate and diagnosis rate of insulinoma have gradually increased. At present, cytotoxic chemotherapy, targeted therapy and peptide receptor radionuclide therapy (PRRT) have improved the clinical cure rate of insulinoma. This article reviews the latest progress in the pathogenesis, diagnosis and treatment of insulinoma.
出处
《临床医学进展》
2023年第5期7378-7385,共8页
Advances in Clinical Medicine
